Health Care/Hospital
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...
2020-06-01 07:30
5290
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
2020-06-01 07:30
5481
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announce...
2020-06-01 07:30
5189
Establishment of the Blue Apple New Frontier Healthcare Fund
HONG KONG, June 1, 2020 /PRNewswire/ -- New Frontier Capital Management Hong Kong has signed a collaborative MOU with Blue Apple Partners to establish the "Blue Apple New Frontier Healthcare Fund" (tentative name; the "Fund") to be jointly managed by both parties. Blue Apple Partners is a h...
2020-06-01 07:00
3964
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company presented fo...
2020-05-31 20:00
2335
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on29 May 2020, researchers at Samsung Medical Center inSeoul, Korea, have found useful prognostic information beyond actionable biomarkers when the Guardant36...
2020-05-30 19:00
3385
Fosun Foundation and Longfor Group donated 40 ventilators to the U.S. hospitals in fight against COVID-19
NEW YORK, May 29, 2020 /PRNewswire/ -- Fosun Foundation together with Longfor Group announce the donation of 40 Breas Vivo 50 ventilators to the hospitals in 21 hospitals located in 11 different states of U.S. to support medical communities fighting againse the COVID-19. The donated 40 ventila...
2020-05-30 02:00
2916
The 2nd Singapore-China Joint Meeting on COVID-19
Joint Press Statement SINGAPORE, May 30, 2020 /PRNewswire/ -- On 28 May 2020, Permanent Secretary Chee Wee Kiong of the Ministry of Foreign Affairs of the Republic of Singapore and Vice Minister Luo Zhaohui of the Ministry of Foreign Affairs ofthe People's Republic of China co-chaired the 2nd Ch...
2020-05-30 00:56
3638
New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib in Advanced NSCLC with METex14 Skipping Alterations
DARMSTADT, Germany, May 29, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced that updated data from the ongoing, single-arm Phase II VISION study evaluating tepotinib* as a single agent in patients with advanced non-small cell lung cancer (NSCLC) withMET exon ...
2020-05-29 20:33
3257
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO)
SUZHOU, China and SHANGHAI, May 29, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, today announced that two presentations were accepted at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program. ...
2020-05-29 20:00
2113
I-Mab Announces Upcoming Participation at June Conferences
SHANGHAI and GAITHERSBURG, Md., May 29, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical ...
2020-05-29 20:00
6168
Mundane Glory: Telling the Story of Chinese Overseas Medical Aid
CHANGSHA, China, May 29, 2020 /PRNewswire/ -- Aired in Mango TV, Mundane Glory
is a series of short documentary that focuses on strivers who work on Chinese
emerging industry. It has been aired in global platforms including Mango TV and
Hunan Satellite TV sinceMay 21st of this year.
2020-05-29 17:41
1791
Zlatko Rihter Appointed New CEO of Moelnlycke
GOTHENBURG, Sweden, May 29, 2020 /PRNewswire/ -- Zlatko Rihter has been appointed President and CEO of the medical solutions company, Moelnlycke Health Care AB. Zlatko Rihter is a Swedish citizen and currently President and CEO of Sweden -based CellaVision, a world-leading provider of digital sol...
2020-05-29 15:13
2658
Jakarta-Based Home of Wellbeing Rumah Remedi Held #stayathome Meditations During the Pandemic
* Regular meditation sessions were free of charge from mid of March until the end ofApril 2020. * By migrating the sessions from offline to online, Rumah Remedi managed to reach individuals residing in various places inIndonesia who needed help during the pandemic. JAKARTA, Indonesia, May 29,...
2020-05-29 12:41
3251
Thailand's Economic Front in Fighting COVID-19
BANGKOK, May 29, 2020 /PRNewswire/ -- Thailand has performed well in containing the COVID-19 outbreak and mitigating its impact. Since27 April 2020, the number of new COVID-19 cases has increased only slightly, while some days saw no new cases at all. About 96 per cent of those infected have full...
2020-05-29 12:20
7599
Overcoming Challenges to Offline Education, Mysavvytutor Advances with New On-Demand App
SINGAPORE, May 29, 2020 /PRNewswire/ — According to a United Nations' report
2020-05-29 10:00
4678
Ping An Voyager Fund Leads Investment in PlusDental to Enhance Modern Dentistry in Europe
HONG KONG and SHANGHAI, May 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) is delighted to announce that its fintech and healthtech investment arm Ping An Global Voyager Fund has invested in digital dentistry pl...
2020-05-29 09:48
14838
Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer
SHANGHAI and SAN FRANCISCO, May 29, 2020 /PRNewswire/ -- Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced positive topline results from the NORA study, the Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA (n...
2020-05-29 07:05
3646
Endofotonics Raises S$12 million in Series B Funding for the Commercialization of its AI Powered Medical Device to Support Clinicians in the Real Time Detection of Early Stomach Cancer
SINGAPORE, May 29, 2020 /PRNewswire/ -- Endofotonics
2020-05-29 07:00
4683
Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells
TOKYO, May 28, 2020 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502, hereinafter "Toshiba") and a team led by ProfessorYozo Nakazawa at the Department of Pediatrics, Shinshu University, (hereinafter "Shinshu University"), have together developed a "tumor-tropic liposome technology" for gene the...
2020-05-28 23:00
7829
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
